Scientists identified an enzyme in animal studies whose activity promotes weight gain and the loss of exercise capacity starting in mid-life. A drug that inhibits the enzyme prevented weight gain in mice, increased fitness levels, and reduced the incidence of obesity and type 2 diabetes. The findings could lead to more effective weight-loss medications. DNA-PKContinue reading “Enzyme drives middle-age weight and fitness changes”